HEALTHCOR MANAGEMENT, L.P. – Neurocrine Biosciences, Inc. Transaction History
HEALTHCOR MANAGEMENT, L.P. portfolio value:
$2.30M
portfolio value
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 21.72K shares | 2.30M | $106.21 | 21.72K |
| Q2 2022 | share | Decrease | -100.00% | -23.48K shares | -2.20M | $97.48 | 0 |
| Q1 2022 | share | Decrease | -93.58% | -342.25K shares | -28.94M | $93.75 | 23.48K |
| Q4 2021 | share | Decrease | -17.95% | -80.00K shares | -11.60M | $84.63 | 365.73K |
| Q3 2021 | share | Increase | +14.30% | 55.75K shares | 4.79M | $95.91 | 445.73K |
| Q2 2021 | share | Increase | 0.00% | 389.98K shares | 37.95M | $97.32 | 389.98K |
| Q1 2021 | share | Decrease | -100.00% | -226.46K shares | -21.70M | $97.25 | 0 |
| Q4 2020 | share | Decrease | -75.57% | -700.61K shares | -67.44M | $95.85 | 226.46K |
| Q3 2020 | share | Increase | +160.58% | 571.3K shares | 45.74M | $96.16 | 927.07K |
| Q2 2020 | share | Decrease | -77.01% | -1.19M shares | -90.55M | $122 | 355.77K |
| Q1 2020 | share | Increase | +91.82% | 740.87K shares | 47.22M | $86.55 | 1.54M |
| Q4 2019 | share | Decrease | -45.97% | -686.61K shares | -47.84M | $107.49 | 806.86K |
| Q3 2019 | share | Decrease | -37.02% | -877.91K shares | -65.63M | $90.11 | 1.49M |
| Q2 2019 | share | Increase | +56.41% | 855.3K shares | 66.64M | $84.43 | 2.37M |
| Q1 2019 | share | Increase | +97.25% | 747.46K shares | 78.68M | $88.1 | 1.51M |
| Q4 2018 | share | Increase | +87.31% | 358.27K shares | 4.43M | $71.41 | 768.63K |
| Q3 2018 | share | Decrease | -48.31% | -383.59K shares | -27.54M | $122.95 | 410.35K |
| Q2 2018 | share | Increase | +14.80% | 102.36K shares | 20.64M | $98.24 | 793.95K |
| Q1 2018 | share | Decrease | -54.65% | -833.40K shares | -60.97M | $82.93 | 691.59K |
| Q4 2017 | share | Decrease | -26.93% | -562.11K shares | -9.57M | $77.59 | 1.52M |
| Q3 2017 | share | Decrease | -18.16% | -463.06K shares | 10.59M | $61.28 | 2.08M |
| Q2 2017 | share | Increase | +108.18% | 1.32M shares | 64.26M | $46 | 2.55M |
| Q1 2017 | share | Increase | +23.88% | 236.1K shares | 14.77M | $43.3 | 1.22M |
| Q4 2016 | share | Increase | 0.00% | 988.9K shares | 38.27M | $38.7 | 988.9K |
| Q3 2016 | share | Decrease | -100.00% | -450K shares | -20.45M | $50.64 | 0 |
| Q3 2016 | call | Decrease | -100.00% | -310K shares | -14.09M | $50.64 | 0 |
| Q2 2016 | call | Increase | 0.00% | 310K shares | 14.09M | $45.45 | 310K |
| Q2 2016 | share | Decrease | -37.93% | -275K shares | -8.22M | $45.45 | 450K |
| Q1 2016 | share | Increase | 0.00% | 725K shares | 28.67M | $39.55 | 725K |